Home > Boards > US Listed > Medical - Healthcare > McKesson Corporation (MCK)

MCK signs agreement with RMCP !!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
OCMillionaire Member Profile
Member Level 
Followed By 2,765
Posts 30,812
Boards Moderated 1
Alias Born 06/29/11
160x600 placeholder
Opioid Makers Hit With Criminal Probe -- WSJ Dow Jones News - 11/27/2019 3:02:00 AM
Opioid Makers, Distributors Fall Following WSJ Report on Federal Probe Dow Jones News - 11/26/2019 1:51:00 PM
Federal Prosecutors Launch Criminal Probe of Opioid Makers, Distributors Dow Jones News - 11/26/2019 1:18:00 PM
AdaptHealth to Buy Patient Care Solutions Business From McKesson Dow Jones News - 11/22/2019 8:44:00 AM
Johnson & Johnson Opioid Verdict Cut -- WSJ Dow Jones News - 11/16/2019 3:02:00 AM
Johnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 Million Dow Jones News - 11/15/2019 5:15:00 PM
McKesson (MCK) Alert: Johnson Fistel Announces Shareholder Class Action Against McKesson Corporation Survives Motion to Dismi... PR Newswire (US) - 11/8/2019 11:59:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 5:52:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 5:50:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/30/2019 4:05:18 PM
McKesson Reports Higher 2Q Revenue Dow Jones News - 10/30/2019 7:47:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2019 7:12:12 AM
McKesson Reports Fiscal 2020 Second-Quarter Results Business Wire - 10/30/2019 7:00:00 AM
McKesson Declares Quarterly Dividend October 23, 2019 Business Wire - 10/23/2019 4:10:00 PM
Opioid Deal Lifts Odds for Broader Accord -- WSJ Dow Jones News - 10/22/2019 3:02:00 AM
Opioid Deal Could Open Door to Bigger Settlement -- Update Dow Jones News - 10/21/2019 4:25:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/21/2019 4:13:16 PM
Distributors Reach Settlement With Ohio Counties in Opioids Case Business Wire - 10/21/2019 11:38:00 AM
Four Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 3rd Update Dow Jones News - 10/21/2019 10:34:00 AM
Four Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 2nd Update Dow Jones News - 10/21/2019 8:57:00 AM
Four Drug Companies Reach Last-Minute Settlement in Opioid Litigation--Update Dow Jones News - 10/21/2019 8:21:00 AM
More Money Demanded in Opioid Settlement Talks Dow Jones News - 10/18/2019 7:57:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2019 5:20:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2019 4:39:56 PM
Talks to Settle Opioid Lawsuits Intensify Dow Jones News - 10/17/2019 6:15:00 PM
OCMillionaire Member Level  Saturday, 11/17/12 03:20:35 PM
Re: None
Post # of 41 
MCK signs agreement with RMCP!!!

Revolutions Medical Signs Distribution Agreement With McKesson
Date : 11/16/2012 @ 1:32PM
Source : MarketWire
Stock : Revolutions Medical Corp. (QB) (RMCP)
Quote : 0.095 0.015 (18.75%) @ 4:35PM

Revolutions Medical Signs Distribution Agreement With McKesson
Print
Alert
Revolutions Medical Corp. (QB) (USOTC:RMCP)
Intraday Stock Chart
Today : Saturday 17 November 2012


Revolutions Medical Corporation (OTCQB: RMCP) announced today that the Company has entered into a vendor and distribution agreement with McKesson Corporation ("McKesson") for the distribution of the Company's RevVac™ auto-retractable vacuum safety syringe in the United States healthcare market. McKesson is one of the leading medical-surgical supply and distribution companies in the United States, while also serving as one of the country's largest pharmaceutical distributors, supplying more than 40,000 pharmacy locations across the U.S. Pursuant to the terms of the vendor and distribution agreement, the RevVac™ auto-retractable vacuum safety syringe is now available to over 550 McKesson sales representatives through their distribution network and order processing system.
Ron Wheet, the Company's Chief Executive Officer and Chairman, stated, "Since introducing the RevVac™ safety syringe to the U.S. health care market in the second quarter 2012, the Company has considered several available options to best manage the roll out of our product. We are very pleased to have the RevVac™ safety syringe distributed by McKesson, one of the best names in health care quality in the world. We believe this relationship will complement our additional sales efforts with MedPro Associates."

About Revolutions Medical Corporation

Revolutions Medical Corporation is a safety medical device and software application company. Its proprietary technologies and products include: the RevVac™ safety syringe, safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS) and prefilled vacuum auto-retraction safety syringes.

For additional information, please visit Revolutions Medical corporate website:

http://www.revolutionsmedical.com/

To be added to the Revolutions Medical investor email list, please email:

investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

CONTACT:



Revolutions Medical Corporation

Investor Relations

Tel.: (843) 606-9461



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist